News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 2, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Annual J.P. Morgan Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Monday, January 8, 2018

Time:

4:00 p.m. Pacific Time

Location:

Westin St. Francis Hotel, San Francisco

Webcast:

http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-calendar

 

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300574081.html

SOURCE Array BioPharma Inc.